Glucagon Function and Counter-Regulatory Hormones

Glucagon is the chief counter-regulatory hormone to insulin, secreted by pancreatic alpha cells when blood glucose falls. It acts mainly on the liver to mobilize glucose by breaking down glycogen and stimulating gluconeogenesis, defending the body against hypoglycemia. Together with other counter-regulatory hormones, epinephrine, cortisol, and growth hormone, glucagon ensures a steady glucose supply to the brain during fasting and stress.

Definition

Glucagon is a peptide hormone secreted by pancreatic alpha cells that raises blood glucose chiefly by stimulating hepatic glycogenolysis and gluconeogenesis; counter-regulatory hormones are the set of hormones (glucagon, epinephrine, cortisol, growth hormone) that oppose insulin and defend against hypoglycemia.

Scope

The topic covers glucagon synthesis and secretion by alpha cells, its hepatic actions on glycogenolysis and gluconeogenesis, the wider system of counter-regulatory hormones that oppose insulin, and the role of alpha-cell dysregulation in hyperglycemia. It also situates the proglucagon-derived peptide GLP-1 within glucose regulation. It is a reference-educational account of normal physiology and does not provide clinical guidance.

Core questions

• How and when do alpha cells secrete glucagon?
• How does glucagon raise blood glucose at the level of the liver?
• Which other hormones act as counter-regulators to insulin and how do they differ?
• How does the insulin-to-glucagon ratio set the body's metabolic direction?
• How does dysregulated glucagon secretion contribute to hyperglycemia?

Key concepts

• Alpha cells and glucagon secretion
• Hepatic glycogenolysis
• Gluconeogenesis
• Counter-regulatory hormones (epinephrine, cortisol, growth hormone)
• Insulin-to-glucagon ratio
• Defense against hypoglycemia
• Proglucagon and GLP-1

Key theories

Bihormonal and glucagon-centric view of glycemic control

Glycemia depends on the balance between insulin and glucagon rather than insulin alone; in this view, excess or inadequately suppressed glucagon, driving hepatic glucose output, is a major contributor to hyperglycemia, complementing the traditional insulin-deficiency model.

Mechanisms

When blood glucose falls, alpha cells secrete glucagon, which binds hepatic glucagon receptors and, through a cAMP-dependent cascade, stimulates glycogen breakdown (glycogenolysis) and new glucose synthesis (gluconeogenesis), raising blood glucose. Glucagon thus opposes insulin, and the insulin-to-glucagon ratio governs whether the liver stores or releases glucose. Other counter-regulatory hormones reinforce this defense: epinephrine acts rapidly to mobilize glucose and limit insulin secretion, while cortisol and growth hormone contribute to a slower, sustained rise. The proglucagon gene also gives rise to GLP-1 in the gut, which conversely enhances glucose-dependent insulin secretion (Dunning & Gerich, 2007; Holst, 2007).

Clinical relevance

Disordered glucagon and counter-regulatory function is clinically important: inappropriately high or unsuppressed glucagon contributes to the hyperglycemia of diabetes, while impaired counter-regulation predisposes to dangerous hypoglycemia, particularly in insulin-treated diabetes. Glucagon and the related GLP-1 system are major foci of metabolic research. This entry describes the physiology and basis of dysregulation for educational reference, not for diagnosis or treatment (Unger & Cherrington, 2012; Mueller et al., 2019).

History

Glucagon was identified as a hyperglycemic factor in pancreatic extracts in the 1920s, soon after insulin, and was later localized to the alpha cell. Roger Unger advanced the bihormonal concept of glucose regulation, arguing that glucagon excess is a key driver of hyperglycemia. The discovery that the proglucagon gene also produces the incretin GLP-1 broadened understanding of the glucagon family in glucose control (Unger & Cherrington, 2012; Holst, 2007).

Debates

How central is glucagon excess to the hyperglycemia of diabetes?

A glucagon-centric view holds that unrestrained alpha-cell activity and hepatic glucose output are major drivers of hyperglycemia, while others emphasize insulin deficiency and resistance as primary; the relative weight of these contributions continues to be discussed.

Key figures

• Roger Unger
• Alan Cherrington
• John Gerich
• Jens Juul Holst
• Daniel Drucker

Seminal works

• unger-cherrington-2012
• dunning-gerich-2007
• holst-2007

Frequently asked questions

What does glucagon do?

It raises blood glucose, mainly by signaling the liver to break down stored glycogen and make new glucose, which is how the body defends against low blood sugar between meals and during fasting.

What are the counter-regulatory hormones?

They are the hormones that oppose insulin and raise blood glucose: glucagon, epinephrine (adrenaline), cortisol, and growth hormone. Together they protect against hypoglycemia.